Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.

Mark E. Mullins, P. Ellen Grant, Bing Wang, Ramón González, Pamela W. SchaeferPubMed 2005

TL;DR

This study investigates how diffusion-weighted MRI (DW-MRI) can help differentiate types of brain damage in patients with cerebral venous sinus thrombosis (CVT). They found that DW-MRI can distinguish between reversible swelling (vasogenic edema) and potentially permanent cell damage (cytotoxic edema), with seizure activity playing a key role in how cytotoxic edema resolves. This distinction is crucial for predicting patient outcomes and guiding treatment.

What Problem Does This Paper Address?

Cerebral venous sinus thrombosis (CVT), a blockage in the brain's venous drainage system, can lead to various brain abnormalities. While T2-weighted MRI can show these abnormalities, it's often difficult to tell if the damage is temporary (like swelling) or permanent (like cell death). This ambiguity makes it hard to predict how a patient will recover and what treatment is best. The researchers aimed to use DW-MRI, a technique known to differentiate between types of edema, to better characterize these parenchymal changes in CVT patients and correlate them with clinical outcomes.

Methods

The study retrospectively analyzed MR images from 13 patients diagnosed with CVT and parenchymal abnormalities. They specifically focused on diffusion-weighted (DW) images and apparent diffusion coefficient (ADC) maps. These images were assessed for signal intensity changes (increased, decreased, or unchanged) compared to the healthy side of the brain. In eight patients, quantitative ADC values were measured in abnormal regions. The researchers then compared these imaging findings with follow-up imaging and clinical outcomes, paying close attention to whether patients had experienced seizures.

Datasets

The study utilized a dataset of 13 patients with CVT who underwent MR imaging between 1994 and 1999. This dataset included T2-weighted, FLAIR, DW, and ADC map images. Follow-up imaging, which could include MR or CT scans, was available for most patients. No new datasets were created or introduced by this study.

Key Insights and Ideas

  • DW-MRI as a differentiator: The core insight is that DW-MRI, particularly ADC maps, can distinguish between different types of parenchymal lesions in CVT. This goes beyond what standard T2-weighted images can offer.
  • Three distinct lesion types: The study identified three key patterns:
  • Elevated diffusion (resolving): These lesions are likely vasogenic edema, characterized by swelling due to leaky blood vessels. They tend to resolve without causing permanent damage.
  • Decreased diffusion (persisting): This pattern suggests cytotoxic edema, indicating cell damage. In patients without seizures, these lesions were more likely to lead to permanent injury.
  • Decreased diffusion (resolving): Interestingly, in patients with seizure activity, lesions with decreased diffusion were more likely to resolve. This suggests that seizures might influence the reversibility of cytotoxic edema in CVT.
  • Seizure activity is a critical factor: The presence or absence of seizures significantly impacts the prognosis of cytotoxic edema in CVT patients. This highlights the importance of integrating clinical history with imaging findings.
  • Location matters, but less than diffusion: While CVT in deep veins was associated with deep gray/white matter lesions and superficial CVT with cortical/subcortical lesions, the diffusion characteristics were more predictive of outcome than lesion location alone.

Key Results

  • Ten patients had follow-up imaging.
  • Four patients had lesions with decreased diffusion that persisted and showed T2 hyperintensity on follow-up, suggesting permanent injury.
  • Three patients with seizure activity had lesions with decreased diffusion that resolved.
  • Seven patients had lesions with elevated diffusion that resolved, consistent with vasogenic edema.
  • The mean ADC values for resolving decreased-diffusion lesions and persisting decreased-diffusion lesions were not statistically significantly different, suggesting that factors beyond the initial ADC value (like seizure activity) are important for predicting resolution.
  • Two patients died, and most others had varying degrees of symptom improvement or persistence.

Limitations and Future Work

  • Retrospective nature: The study was retrospective, meaning data was collected after the fact, which can introduce biases.
  • Small sample size: With only 13 patients, the findings may not be generalizable to a larger population.
  • Variability in follow-up: Not all patients had follow-up MR imaging; some had CT scans, and three had no follow-up at all, potentially limiting the assessment of lesion evolution.
  • Exclusion bias: Patients with normal initial examinations were not included, which could skew the results if these patients later developed adverse outcomes.
  • Lack of outcome scales: The retrospective nature prevented a formal assessment of clinical outcome scales.
  • T2* sequences: T2* sequences, useful for detecting hemorrhage, were not universally performed, which could affect ADC calculations in hemorrhagic areas.

The authors suggest that DW-MRI, combined with clinical history (especially seizure activity), may be important for prospectively determining the severity of irreversible injury, evaluating new therapeutic agents, and guiding patient management. Future work could involve larger, prospective studies to confirm these findings and explore the mechanisms behind seizure-induced resolution of cytotoxic edema in CVT.

Summary updated

Abstract

DW imaging in these patients disclosed three lesion types: lesions with elevated diffusion that resolved, consistent with vasogenic edema; lesions with low diffusion that persisted, consistent with cytotoxic edema in patients without seizure activity; and lesions with low diffusion that resolved in patients with seizure activity. This information may be important in prospectively determining severity of irreversible injury and in patient treatment.
BibTeX
@inproceedings{mullins2005parenchymal,
  author = {Mark E. Mullins and P. Ellen Grant and Bing Wang and Ramón González and Pamela W. Schaefer},
  title = {{Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.}},
  booktitle = {PubMed},
  year = {2005},
}

Loading related content...

Figure